Acadia Pharma (ACAD) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.37 +1.14%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
